OFFICE OF FISCAL ANALYSIS

Legislative Office Building, Room 5200

Hartford, CT 06106 (860) 240-0200

http://www.cga.ct.gov/ofa

SB-465

AN ACT REQUIRING NEWBORN SCREENING FOR ADRENOLEUKODYSTROPHY.

AMENDMENT

LCO No.: 7469

File Copy No.: 107

Senate Calendar No.: 152


OFA Fiscal Note

State Impact:

Agency Affected

Fund-Effect

FY 14 $

FY 15 $

FY 16 and Out Years $

Public Health, Dept.

GF - Cost

None

None

70,000

Public Health, Dept.

GF - Potential Revenue Gain

None

None

70,000

NET STATE IMPACT

0

0

0

Municipal Impact: None

Explanation

The amendment strikes the language in the underlying bill and its associated fiscal impact and replaces it with language that is not anticipated to result in a fiscal impact to the Department of Public Health in either FY 14 or FY 15 as newborn screening for adrenoleukodystrophy is not required until (1) certain conditions are met or (2) on or after 7/1/15. 

The Out Years

In the out years, assuming that criteria described in the bill has occurred, DPH would incur a cost of approximately $70,000 annually for testing supplies and could generate General Fund revenue of the same amount should DPH choose to increase the newborn screening fee by $1.67.1  

The preceding Fiscal Impact statement is prepared for the benefit of the members of the General Assembly, solely for the purposes of information, summarization and explanation and does not represent the intent of the General Assembly or either chamber thereof for any purpose. In general, fiscal impacts are based upon a variety of informational sources, including the analyst's professional knowledge. Whenever applicable, agency data is consulted as part of the analysis, however final products do not necessarily reflect an assessment from any specific department.

1 This assumes the birth of 42,000 Connecticut newborns annually. Per CGS Sec. 19a-55, DPH has the authority to set the fee associated with newborn screening.